feed,title,long_url,short_url
Benzinga,Adcomm Split On FDA Approval For ChemoCentryx's Vasculitis Candidate,https://benzinga.com/general/biotech/21/05/21008128/adcomm-split-on-fda-approval-for-chemocentryxs-vasculitis-candidate,https://j.mp/33kQpLr
Benzinga,Hpq poised to take advantage of the need for silicon in batteries,https://benzinga.com/news/21/05/21008598/hpq-poised-to-take-advantage-of-the-need-for-silicon-in-batteries,https://j.mp/3f3rUYj
